Core Viewpoint - ST Yilianzhong's stock closed at 4.04 yuan, down 1.70%, with a latest price-to-book ratio of 6.07 and a total market capitalization of 1.737 billion yuan [1] Financial Performance - For the third quarter of 2024, the company reported operating revenue of 335 million yuan, a year-on-year decrease of 29.72%, and a net profit of -67,993,078.91 yuan, reflecting a year-on-year decline of 153.10%, with a gross profit margin of 46.38% [2] Business Overview - The main business of Yilianzhong Information Technology Co., Ltd. includes digital medical insurance, digital healthcare, digital social security, digital technology, and digital services. Key products consist of customized software and IC, technical services, system integration, hardware, insurance brokerage, and other services [1] - The company has received several awards for its achievements in blockchain technology and digital health initiatives, including the FISCOBCOS Open Source Ecological Excellence Contribution Award and recognition at the 2023 Digital China Construction Summit [1] Market Position - The company's price-to-earnings ratio (TTM) is -10.93, with a static PE of 46.89 and a price-to-book ratio of 6.07, compared to the industry average PE of 70.88 and a market capitalization of 1.216 billion yuan [3]

Core Viewpoint - The intelligent material pre-review platform developed by Yilianzhong leverages technology innovation to enhance the efficiency of government services, addressing traditional pain points such as low efficiency and high error rates through the integration of AI and big data [1][6]. Dimension Summaries Dimension One: Speedy Response - The platform utilizes OCR and large language models to achieve multi-dimensional intelligent analysis of materials, reducing the review time from 15-30 minutes to just 2-5 minutes, thus significantly enhancing the efficiency of government services [1]. Dimension Two: Precise Verification - The platform employs intelligent algorithms to compare submitted materials against approval standards, identifying various issues such as omissions and inconsistencies, resulting in an over 90% approval rate for pre-reviewed materials and a 95% reduction in review errors [2]. Dimension Three: Flexible Configuration - The platform features a configurable backend management interface that allows for quick adaptation of pre-review rules and processes to meet diverse needs across different regions and departments, showcasing its flexibility and adaptability [3]. Dimension Four: One-Stop Service - Adhering to the "one-stop service" concept, the platform integrates self-service, window service, and mobile service, ensuring comprehensive online coverage of high-frequency matters and enhancing user experience by simplifying processes [4]. Dimension Five: Security and Compliance - The platform establishes a comprehensive data protection system, employing encryption and access control to ensure the security of materials during transmission, storage, and use, thereby reinforcing the foundation of digital government services [5]. Value Empowerment Value One: Efficiency Revolution - The implementation of the platform has led to a 90% reduction in material pre-review time and a 70% decrease in processing time, transforming government services from labor-intensive to technology-driven [7]. Value Two: Cost Optimization - The platform facilitates a win-win situation for both enterprises and government departments by reducing the number of visits required by users and significantly lowering operational costs for government departments, with a 60% reduction in window modification rates and a 90% decrease in manual review workload [9]. Value Three: Data-Driven Governance - The data accumulated by the platform serves as a digital think tank for policy optimization, enabling the transition from experience-based decision-making to data-driven governance, while ensuring compliance and security throughout the digital transformation process [10].

Core Insights - ST Yilianzhong's stock closed at 4.08 yuan, up 1.24%, with a latest price-to-book ratio of 6.13 and a total market capitalization of 1.754 billion yuan [1] - The company has 19,004 shareholders as of April 10, 2025, a decrease of 687 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Company Overview - ST Yilianzhong focuses on digital healthcare, digital medical services, digital social security, digital technology, and digital services [1] - Key products include customized software and IC, technical services, system integration, hardware, insurance brokerage, and other services [1] - The company has received several awards for its blockchain technology achievements and innovative digital health solutions [1] Financial Performance - For the third quarter of 2024, the company reported revenue of 335 million yuan, a year-on-year decrease of 29.72%, and a net loss of approximately 67.99 million yuan, a year-on-year decline of 153.10% [2] - The sales gross margin stands at 46.38% [2] Market Comparison - ST Yilianzhong's price-to-earnings ratio (TTM) is -11.03, while the industry average is 72.15 [2] - The company's market capitalization is 1.754 billion yuan, compared to the industry median of 5.563 billion yuan [2]

Group 1 - The core viewpoint of the articles highlights the financial performance and achievements of ST Yilianzhong, indicating a significant decline in revenue and net profit while showcasing various awards and recognitions in digital healthcare and technology [1][2] Group 2 - As of March 31, 2025, ST Yilianzhong had 19,691 shareholders, a decrease of 115 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The company specializes in digital healthcare services, including digital medical insurance, digital healthcare, digital social security, and digital technology services, with products such as customized software, technical services, and system integration [1] - The company received the FISCOBCOS Open Source Ecological Excellence Contribution Award for its achievements in blockchain technology and was recognized for its innovative digital healthcare solutions at various national events [1] - The latest financial report for Q3 2024 shows a revenue of 335 million yuan, a year-on-year decrease of 29.72%, and a net loss of approximately 67.99 million yuan, reflecting a year-on-year decline of 153.10%, with a gross profit margin of 46.38% [2] - The company's price-to-earnings ratio (PE) is reported at -11.12 (TTM) and 47.70 (static), with a price-to-book ratio of 6.17 and a total market capitalization of 1.767 billion yuan [2]

来源：金融界 资金流向方面，4月2日，ST易联众主力资金净流入842.54万元，近5日总体呈流入状态，5日共流入 3731.81万元。 易联众信息技术股份有限公司的主营业务为数字医保业务、数字医疗业务、数字人社业务、数字科技业 务和数字服务业务。主要产品有定制软件及IC、技术服务、系统集成及硬件、保险经纪、其他服务。公 司因区块链技术方面的成就荣获FISCOBCOS开源生态卓越贡献奖，研发的"医保零星报销智能识别系 统"荣获2023年第六届数字中国建设峰会"十佳数字普惠案例"，研发的"宁德医保智能自动办理平台"入 选2023年数字政府五十佳优秀创新案例，承建的厦门退休人员服务系统项目获得数字厦门2023年度优秀 共享案例评选全市第一名，成为数字福建2023年度公共数据资源共享应用优秀案例；公司与吉林大学第 一医院合作参与国家卫健委"第一届全国数字健康创新应用大赛"，并在"全国检查检验检查结果互通共 享方案设计"赛道获得了优胜奖。 最新一期业绩显示，2024年三季报，公司实现营业收入3.35亿元，同比-29.72%；净利润-67993078.91 元，同比-153.10%，销售毛利率46.38%。 序号股票简称 ...

证券代码：300096 证券简称：ST易联众 公告编号：2025-006 易联众信息技术股份有限公司 关于公司股票被实施其他风险警示相关事项的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 根据《深圳证券交易所创业板股票上市规则》相关规定，因易联众信息技术 股份有限公司（以下简称"公司"）所涉相关违规担保/违规借款情形尚未完全 消除，公司股票将继续被实施其他风险警示（ST）。 一、公司被实施其他风险警示的原因 公司于 2023 年 11 月 28 日披露了《关于存在违规担保、违规借款暨公司涉 及重大诉讼及仲裁事项的公告》（公告编号：2023-077），经自查，公司发现存在 未履行任何内控审批/董事会/股东大会审议决策程序，为原实际控制人/控股股 东/时任董事长张曦先生及其关联方提供违规担保，以及张曦先生以公司名义签 署违规借款的情形。截至本公告披露日，公司相关违规担保/违规借款事项尚未 完全消除。 根据《深圳证券交易所创业板股票上市规则》第 9.4 条、第 9.5 条相关规 定，公司股票被实施其他风险警示。具体详见公司于 2023 年 1 ...

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of ST Yilianzhong, indicating a significant decline in revenue and net profit for the third quarter of 2024 compared to the previous year [2] - As of March 31, ST Yilianzhong's stock closed at 4.22 yuan, marking a 2.93% increase, with a latest price-to-book ratio of 6.34, which is the lowest in 238 days, and a total market capitalization of 1.815 billion yuan [1] - The company has experienced a net inflow of main funds amounting to 11.04 million yuan on March 31, with a total inflow of 29.93 million yuan over the past five days, indicating a positive trend in fund movement [1] Group 2 - For the third quarter of 2024, ST Yilianzhong reported an operating income of 335 million yuan, reflecting a year-on-year decrease of 29.72%, and a net profit loss of approximately 67.99 million yuan, which is a 153.10% decline compared to the previous year [2] - The company's gross profit margin stands at 46.38%, which is a critical metric for assessing its profitability in the current market environment [2] - The company has received several accolades for its contributions to digital healthcare and technology, including awards for its blockchain achievements and innovative digital health applications [1]

Group 1 - ST Yilianzhong's stock closed at 3.9 yuan, up 3.17%, with a latest price-to-book ratio of 5.86 and a total market value of 1.677 billion yuan [1] - The net inflow of main funds on March 26 was 3.1041 million yuan, with a total inflow of 6.3381 million yuan over the past five days [1] - The company specializes in digital medical insurance, digital healthcare, digital social security, digital technology, and digital services [1] Group 2 - For the third quarter of 2024, the company reported operating revenue of 335 million yuan, a year-on-year decrease of 29.72%, and a net loss of approximately 67.99 million yuan, a year-on-year decline of 153.10% [2] - The company's sales gross margin was 46.38% [2] - The company has received several awards for its blockchain technology achievements and digital healthcare innovations [1][2]

Group 1 - ST Yilianzhong's stock closed at 3.76 yuan, down 3.84%, with a latest price-to-book ratio of 5.65 and a total market value of 1.617 billion yuan [1] - As of March 10, 2025, the number of shareholders for ST Yilianzhong increased to 20,440, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] - The company specializes in digital medical insurance, digital healthcare, digital social security, digital technology, and digital services, with products including customized software, technical services, system integration, and insurance brokerage [1] Group 2 - For the third quarter of 2024, the company reported operating revenue of 335 million yuan, a year-on-year decrease of 29.72%, and a net profit of -67,993,078.91 yuan, a year-on-year decrease of 153.10%, with a gross profit margin of 46.38% [2] - The company's price-to-earnings ratio (TTM) is -10.17, while the industry average is 73.18, indicating significant underperformance compared to peers [2] - The company has received several awards for its achievements in blockchain technology and digital health innovation, including recognition at the Digital China Summit and the National Health Commission's digital health innovation competition [1][2]

易联众信息技术股份有限公司 证券代码：300096 证券简称：ST易联众 公告编号：2025-005 上述交易的具体情况详见公司于 2023 年 5 月 24 日、2023 年 10 月 23 日在中 国证监会指定信息披露网站巨潮资讯网（http://www.cninfo.com.cn）上披露的 《关于转让控股子公司厦门市易联众易惠科技有限公司全部股权的公告》（公告 编号：2023-039）、《关于转让控股子公司厦门市易联众易惠科技有限公司全部 股权的进展公告》（公告编号：2023-069）。 二、本次股权转让的进展情况 公司已于今日收到腾云大健康支付的易惠科技 56.5217%股权的第三期转让款 1,404.5642 万元。至此，根据股权转让协议的相关约定，腾云大健康已完成股权 转让价款的支付义务，公司与腾云大健康将继续对未尽事宜履行相应责任及义务。 特此公告。 易联众信息技术股份有限公司 关于转让控股子公司全部股权的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、本次股权转让的基本情况 易联众信息技术股份有限公司（以下简称"公司"）于 202 ...